The Aula L’H program on L’Hospitalet digital television, specialized in education, together with the Institut Bellvitge and IDIBELL, have carried out, throughout the 2021-22 academic year, a complete edition of the Women of Science section, entirely dedicated to disseminating the research work, the research career and the personality of five IDIBELL scientists.
Twenty-nine reference centers from the United States, Canada, the Netherlands, Italy, France, and Spain, including IDIBELL, have participated in an international multicenter study that validated a model for predicting the risk of ventricular arrhythmias and sudden death in arrhythmogenic cardiomyopathy of the right ventricle (ARVC).
Validated a tool that assesses the risk of sudden death due to a heart disease Read More »
The drug inhibits the S6K1 protein, which is essential for the development of new fat cells, responsible for the disproportionate growth of fat deposits in obese people.
IDIBELL and Hospital de Bellvitge are studying the efficacy of Efavirenz, an antiretroviral against HIV, for the treatment of Niemann Pick type C in a clinical trial.
A new study produces comparable estimates of screening coverage for 202 countries and territories
The spin-off that emerged from IDIBELL and the Catalan Institute of Oncology is developing new therapeutic alternatives for advanced cancers and a screening system for these patients.
AtG Therapeutics completes a seed financing round raising more than half a million euros Read More »
The study, based on an animal experimental model, shows that when physiological stress exceeds the capacity of white adipose tissue to respond, it reaches a point of no return where it loses its metabolic plasticity.
White adipose tissue is the most vulnerable to metabolic changes caused by obesity Read More »
The study, led by researchers from IDIBELL, ICO and Hospital Clínic-IDIBAPS, analyzes the genetic variants associated with the risk of developing the cancer and should make it possible to reduce the number of unnecessary colonoscopies.
A model that improves screening of colorectal cancer has been developed Read More »
These grants promote the creation of new products and companies in life sciences and health, as well as help transfer the research results to society and the market.
A Josep Maria Aran’s project financed by CaixaResearch Validate grants Read More »
The IDIBELL Clinical Research and Clinical Trials Unit (UICEC), managed by the HUB’s Clinical Pharmacology service and led by the head of this service, Dr. Pilar Hereu, achieved recertification of the quality management system.
The Clinical Research and Clinical Trials Unit obtains the ISO 9001:2015 recertification Read More »
